Aim To compare the prevalence of metabolic syndrome (MS) using the World Health Organisation (WHO), Adult Treatment Panel III (ATPIII) and International Diabetes Federation (IDF) criteria of MS in an urban south Indian population, and their ability to identify coronary artery disease (CAD) in males and females.
Introduction
Metabolic syndrome (MS) refers to a clustering of metabolic risk factors including central obesity, glucose intolerance, hyperinsulinemia, low HDL cholesterol, high triglycerides and hypertension [1] . People with MS are twice as likely to die from, and three times as likely to develop, myocardial infarction (MI) or stroke compared to people without MS [2] . They also have a five-fold greater risk of developing type 2 diabetes (if not already present) [3] . MS is increasingly being recognised as a risk factor for cardiovascular disease (CVD) [2] and cardiovascular mortality [4] . Unfortunately, there is no internationally agreed definition for MS and, hence, estimates of MS vary substantially across populations depending on the criteria used. The World Health Organisation (WHO) proposed a definition of MS in 1999 [5] and the National Cholesterol Education Program Expert Panel (NCEP) and Adult Treatment Panel III (ATPIII) published a working definition in 2001 [6] . Recently, the International Diabetes Federation (IDF) Consensus group has come out with another definition [7] . The aim of the present study is to compare the prevalence of MS in an urban South Indian population using the WHO, ATPIII and IDF definitions and their ability to identify coronary artery disease (CAD) in males and females. There are few reports on the prevalence of MS using all three definitions and none from India, which currently has the largest number of people in the world with diabetes [8] .
Study design
The Chennai Urban Rural Epidemiology Study (CURES) is a large cross-sectional study done on a representative population of the metropolitan city of Chennai (formerly Madras) in southern India with a population of 4.3 million people. The detailed study design of CURES is described elsewhere [9] and the sampling frame is shown in our website http://www.mvdsc.org/mdrf/WORLD/pages/chennai. html. Briefly, of the 155 Corporation wards in Chennai, 46 wards were randomly selected to provide a total sample size of 26 001 individuals ≥20 years of age. The institutional ethical committee approval was obtained and informed consent was obtained from all study subjects. Phase 1 of CURES was conducted in the field and involved a door-to-door survey of 26 001 individuals. A detailed questionnaire was administered to all study subjects to collect information regarding demographic, socio-economic, behavioural and health status. A fasting capillary blood sugar, blood pressure and basic anthropometric measures were done in all eligible individuals. Phase 2 of CURES deals with studies on the prevalence of microvascular and macrovascular complications of diabetes. Phases 1 and 2 are not discussed further in this article.
In Phase 3 of CURES, every tenth subject recruited in Phase 1 (n = 2600) was invited to our centre for detailed anthropometric measurements and biochemical tests. Of these, 2350 participated in the study (response rate: 90.4%).
All the study subjects underwent an oral glucose tolerance test (OGTT) using a 75 g glucose load, except self-reported diabetic subjects for whom fasting venous plasma glucose (PG) was measured. The fasting blood sample was taken, after ensuring 8 h of overnight fasting, for estimation of PG and serum lipids using a Hitachi 912 Autoanalyser (Roche Diagnostics GmbH, Mannheim, Germany) utilising kits supplied by Boehringer Mannheim (Mannheim, Germany). Glycated hemoglobin (HbA 1c ) was measured by the High-Pressure Liquid Chromatography (HPLC) method using the Variant machine (BIORAD, Hercules, California).
Anthropometric measurements including weight, height, waist and hip measurements were obtained using standardised techniques [9] . The blood pressure was recorded in the right upper limb in the sitting position, to the nearest 2 mmHg, using a mercury sphygmomanometer (Diamond Deluxe BP apparatus, Pune, India).
Definitions
Body mass index (BMI) was calculated using the formula: weight (Kg)/height (m) 2 .
Waist circumference
The waist was measured using a non-stretchable fibre measuring tape. The subjects were asked to stand erect in a relaxed position with both feet together on a flat surface; one layer of clothing was accepted. Waist girth was measured as the smallest horizontal girth between the costal margins and the iliac crests at minimal respiration.
Hip circumference
Hip measure was taken as the greatest circumference at the level of greater trochanters (the widest portion of the hip) on both sides. Measurements were made to the nearest centimeter.
Waist and hip ratio (WHR) was calculated by dividing waist circumference (cm) by hip circumference (cm).
Blood pressure was recorded in the sitting position in the right arm, to the nearest 1 mmHg, using the mercury sphygmomanometer. Two readings were taken 5 min apart and mean of the two was taken as the blood pressure.
Coronary artery disease (CAD)
A resting 12-lead electrocardiogram (ECG) was carried out on 2199 subjects (response rate: 85%).
Possible CAD was diagnosed on the basis of a documented past history of MI or drug treatment for CAD and/or Minnesota codes 1-1-1 to 1-1-7 (Q-wave changes), 4-1 to 4-2 (ST segment depression) or 5-1 to 5-3 (T-wave abnormalities).
Probable CAD was diagnosed on the basis of documented history of MI or the presence of Q-waves on ECG.
Criteria for metabolic syndrome
The three criteria used for defining MS are shown in Table 1 .
Insulin resistance for the WHO criteria was calculated using the homeostasis assessment (HOMA) model using the following formula: fasting insulin (µLU/mL) × fasting glucose (mmol/L)/22.5. Subjects whose HOMA insulin resistance values were above the 4th quartile for the non-diabetic population (i.e. >2.58) were considered to have insulin resistance (homeostasis assessment insulin resistance (HOMA-IR)).
Statistics
Statistical analyses were performed using SPSS for Windows version 10.0 software (SPSS Inc., Chicago, Illinois). t tests were used for continuous variable and chisquare test for proportions. Kappa (κ) statistics was used for finding the agreement between the three definitions. P-value <0.05 was considered significant.
Results
The mean age of the study population (n = 2350) was 40 ± 13 years and 47% (n = 1096) of the subjects were males. Figure 1 shows that the prevalence and number of individuals with MS were 23.2% (n = 546), 18.3% (n = 430) and 25.8% (n = 607) according to the WHO, ATPIII and IDF definitions respectively. Only 224 subjects were identified to have MS by all three criteria. The prevalence of MS was higher in females by ATPIII criteria (males, 17.1%, females, 19.4%, p = 0.149) and IDF criteria (males, 23.1%, females, 28.2%, p = 0.005), but it was higher in males by WHO criteria (males, 27.3%, females, 19.7%, p < 0.001). Table 2 shows that subjects having MS according to WHO criteria were older (47 ± 12 years; p < 0.05) and had significantly lower BMI ( p < 0.05), waist ( p < 0.05) and hip circumference ( p < 0.05) compared to those with MS based on IDF and ATPIII criteria. Subjects with MS based on IDF criteria had significantly lower values of fasting PG ( p < 0.05) and glycated haemoglobin ( p < 0.05) compared to those with MS based on ATPIII and WHO criteria. Mean serum triglyceride levels ( p < 0.05) were higher in subjects with MS defined by ATPIII criteria than by IDF criteria. Waist-to-hip ratio, systolic and diastolic blood pressure, serum cholesterol and HDL cholesterol did not differ in individuals identified by the three criteria.
According to the WHO criteria, obesity was present in 57% (males, 65.8% and females, 49.4%), dyslipidemia in 41.7% (males, 46.7% and females, 37.4%), raised blood pressure in 20% (males, 23.2% and females, 17.2%) and microalbuminuria in 13.7% (males, 12.1% and females, 15.0%) of the study population.
Impaired fasting glucose (IFG) (including self-reported diabetes) was detected in 20.9% (males, 24.2% and females, 18.0%) and 14.7% of individuals (males, 17.8% and females, 12.0%) on the basis of IDF and ATPIII criteria respectively. Abdominal obesity was present in 49.2% (males, 38.5% and females, 58.3%) and 18.5% (males, 6.2% and females, 29.2%) of the subjects on the basis of IDF and ATPIII criteria, respectively. Raised blood pressure was seen in 31.2% (males, 35.3% and females, 27.6%), increased triglycerides in 25.2% (males, 31.0% and females, 20.1%) and decreased HDL cholesterol levels in 63.5% (males, 55.4% and females, 70.6%) of the subjects, which is similar using both ATPIII and IDF criteria. It was also noted that 78.6%, 84.1% and 80.3% of the subjects had at least one abnormality and 1.7%, 2.7% and 1.2% had all five abnormalities according to WHO, IDF and ATPIII criteria, respectively (not shown in table). The prevalence of MS increased with age until the age of 69 and decreased thereafter in all three groups. Even in the age group of 20-29 years, the prevalence of MS ranged from 5.1-8.9% depending on the criteria used to define MS (Figure 2) .
The κ statistics for agreement between IDF with that of ATPIII and WHO criteria were 0.58 ( p < 0.001) and 0.44 ( p < 0.001), respectively. The agreement between ATPIII and WHO criteria was 0.48 ( p < 0.001).
Possible coronary artery disease was present in 185 subjects (62 men, 33.5%), and 37.3%, 23.8% and 32.4% of these subjects were identified by WHO, ATPIII and IDF criteria, respectively. It is possible that subjects with T-wave changes (Minnesota codes 5-1 to 5-3) (Figure 3(a) and (b) ). However, among females, there was no difference in the identification of CAD by the three criteria -'possible' CAD (WHO 26.7%, ATPIII 26.0% and IDF 31.7%), 'probable' CAD (WHO 40%, ATPIII 43.3% and IDF 43.3%), (Figure 3 (a) and (b)). Most of the earlier reports on MS have been based on studies on Europeans. Asian Indians have very high rates of diabetes [8] and premature CAD [12] . Also, different waist cut-offs have been proposed for Asians [13] . The IDF and WHO have called for more studies on MS using different criteria for MS in different ethnic groups. This study provides the first report on the prevalence of MS among Asian Indians using the three definitions (WHO, ATPIII and IDF). We found the prevalence of MS in our study population to be 23.2%, 18.3% and 25.8% using the WHO, ATPIII and IDF definitions, respectively. Table 4 presents a survey of the literature showing the prevalence of MS reported in different populations. In previous studies, the prevalence of MS has varied widely, primarily owing to different definitions of the syndrome or selection of different subgroups. Very few studies have been done in India on the prevalence of MS and most were done using ATPIII criteria and one study using EGIR criteria. The prevalence of MS in the present study is much lower than that reported in an earlier study in urban Indian adults aged 20-75 years, in which the prevalence was reported to be 41.1% [14] . However, that study was done in a smaller sample size (n = 475), used the modified ATPIII criteria and excluded self-reported diabetic subjects. The age-adjusted prevalence of MS based on ATPIII criteria in Jaipur (urban North Indian population) was 24.9% [15] . In the Chennai Urban Population Study (CUPS), the prevalence of MS as defined by EGIR was found to be 11.2% (18.7% in the middle-income and 6.5% in the low-income groups), showing a significant difference even within an urban environment in different socio-economic groups [16] .
Prevalence of metabolic syndrome
Results of the Singapore National Health Survey shows a higher prevalence of MS among the Asian Indians (28.8%) compared to Malays (24.2%) and Chinese (14.8%) [21] . It is noteworthy that the prevalence rates among Indians in Singapore are similar to the rates in the present study done on urban Indians. The National Health and Nutrition Examination Survey (NHANES) III in the United States shows an age-adjusted prevalence of MS in 23.7% as defined by ATPIII criteria [35] . The prevalence of MS in a subgroup of older participants (≥60 years) from a Cardiovascular Health Study (CHS) was 28.1% by ATPIII criteria and 21.0% by WHO criteria [33] . The MS prevalence among workers aged 30-60 years using ATPIII criteria was reported to be 12% for Japanese, 13% for Koreans and 16% for Mongolians [32] . In the United States, 39% of adults were classified as having MS using the IDF criteria, a figure that is higher than that estimated by the ATPIII definition (34.5%) [29] . Similarly, in a study done in South Australia, the prevalence of MS was higher using the IDF criteria (22.8%) as compared to ATPIII criteria (15%) [30] . This is consistent with the present study, in which the prevalence of MS based on IDF criteria is higher (25.8%) than that estimated by ATPIII criteria (18.3%). We also found that the prevalence of MS increased with age irrespective of the definitions used. It is noteworthy that 5.1-8.9% of the subjects in the age group 20-29 years had MS, depending on the definition used. The higher prevalence of MS at younger ages in Asian Indians is of particular concern, as it means that they will have a more prolonged exposure to the atherosclerotic risk factors associated with MS. Studies have shown that prolonged exposure to atherosclerotic risk factors before the onset of diabetes could also contribute to the excess mortality in Asian Indians, which was observed in a study that compared Indians, Malays and Chinese [36] .
In the present study, the concordance of subjects with MS based on IDF criteria with that of ATPIII and WHO was 0.58 and 0.44, respectively, and only 224 subjects were deemed to have MS based on all three criteria. A study in northern Mexico had shown that the IDF has a high concordance (0.87) with ATPIII definition, identifying similar proportions of subjects with MS and a low concordance (0.51) with the WHO definition. Results of the Cardiovascular Health Study (CHS) show an 80% concordance in classifying subjects by ATPIII and WHO criteria [33] . In the Hoorn study, 60-80% agreement was noted among various definitions such as ATPIII, WHO, EGIR and AACE [37] . Thus, the agreement between different definitions of MS appears to vary in different ethnic groups, which is likely due to the different cutoff points used. Despite the fact that the three criteria share most of the components, they still misclassify a large number of subjects as having MS in this urban south Indian population.
To examine the definition of MS that was more strongly associated with the risk for CVD, we compared the correlation of CAD with MS defined by the three definitions. Overall, the prevalence of CAD was four times higher in subjects with MS diagnosed using the WHO criteria, whereas it was two-fold higher on the basis of IDF and ATPIII criteria. The possible explanation is that since insulin resistance is included as one of its criteria, the WHO definition may identify people who are more insulin resistant than the other two criteria. Another interesting observation is that the WHO criteria mark out a higher population for CAD risk in males but not in females. The possible explanation for this is that metabolic abnormalities associated with insulin resistance tend to cluster more in males than in females. Lehto et al [38] have shown that metabolic abnormalities predict CAD better in males than in females.
The strengths of the present study are that the subjects studied are representative of the urban population of Chennai, the sample size is large (n = 2350) and the response rate is very good (90.4%). However, the crosssectional nature of the design does not allow for causeeffect conclusions to be made.
In conclusion, we report that in this urban adult Asian Indian population, a high prevalence of MS (approximately one-quarter of adults) is seen using all three criteria, although they seem to identify different individuals. Among men, the WHO MS criteria identify a greater number of subjects with CAD, compared to the ATPIII or IDF criteria. However, among women there was no difference in the identification of CAD subjects with respect to the three definitions used.
